Thymoma’s immune environment is unique, featuring thymic epithelial disruption leading to autoimmunity (e.g., myasthenia gravis) and heightened NK and monocyte involvement, contrasting with PD-L1-dominant evasion in lung cancer or B cell–centric dysregulation in lymphoma[21–23]. The gene discussed is CD274; the disease is lung carcinoma.